Benedict Cross
Company: Phoremost
Job title: Chief Technology Officer & Head of Platform
Seminars:
A Systematic Protein Editing Platform to Unlock Molecular Glue Discovery 1:30 pm
Describing the challenges of monovalent drug discovery for induced proximity Introducing GlueSEEKER™, a new platform to enable MGD drug discovery Demonstration that E3 effector protein engineering can deliver neomorphic activityRead more
day: Post-Conference Focus Day
Chair’s Opening Remarks 8:20 am
day: Post-Conference Focus Day